DE140254C
(pt)
|
|
|
|
|
US6458772B1
(en)
|
1909-10-07 |
2002-10-01 |
Medivir Ab |
Prodrugs
|
GB924246A
(en)
|
1958-12-23 |
1963-04-24 |
Wellcome Found |
Purine derivatives and their preparation
|
US3116282A
(en)
|
1960-04-27 |
1963-12-31 |
Upjohn Co |
Pyrimidine nucleosides and process
|
GB984877A
(en)
|
1962-08-16 |
1965-03-03 |
Waldhof Zellstoff Fab |
Improvements in and relating to 6-halonucleosides
|
GB1163103A
(en)
|
1965-11-15 |
1969-09-04 |
Merck & Co Inc |
Ribofuranosyl Purine Derivatives
|
FR1498856A
(pt)
|
1965-11-15 |
1968-01-10 |
|
|
FR1521076A
(fr)
|
1966-05-02 |
1968-04-12 |
Merck & Co Inc |
Nucléosides de purines substituées
|
DE1695411A1
(de)
|
1966-05-02 |
1971-04-15 |
Merck & Co Inc |
Substituierte Purin-Nucleoside und Verfahren zu deren Herstellung
|
US3480613A
(en)
|
1967-07-03 |
1969-11-25 |
Merck & Co Inc |
2-c or 3-c-alkylribofuranosyl - 1-substituted compounds and the nucleosides thereof
|
DE2122991C2
(de)
*
|
1971-05-04 |
1982-06-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden
|
US3798209A
(en)
*
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
USRE29835E
(en)
|
1971-06-01 |
1978-11-14 |
Icn Pharmaceuticals |
1,2,4-Triazole nucleosides
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
JPS4848495A
(pt)
|
1971-09-21 |
1973-07-09 |
|
|
US4022889A
(en)
*
|
1974-05-20 |
1977-05-10 |
The Upjohn Company |
Therapeutic compositions of antibiotic U-44,590 and methods for using the same
|
DE2508312A1
(de)
|
1975-02-24 |
1976-09-02 |
Schering Ag |
Neues verfahren zur herstellung von nucleosiden
|
US4058602A
(en)
|
1976-08-09 |
1977-11-15 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Synthesis, structure, and antitumor activity of 5,6-dihydro-5-azacytidine
|
DE2757365A1
(de)
*
|
1977-12-20 |
1979-06-21 |
Schering Ag |
Neues verfahren zur herstellung von nucleosiden
|
DD140254A1
(de)
|
1978-12-04 |
1980-02-20 |
Dieter Baerwolff |
Verfahren zur herstellung von 4-substituierten pyrimidin-nucleosiden
|
DE2852721A1
(de)
|
1978-12-06 |
1980-06-26 |
Basf Ag |
Verfahren zur reindarstellung von kaliumribonat und ribonolacton
|
US4239753A
(en)
|
1978-12-12 |
1980-12-16 |
The Upjohn Company |
Composition of matter and process
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
US4906474A
(en)
|
1983-03-22 |
1990-03-06 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
US4622219A
(en)
|
1983-06-17 |
1986-11-11 |
Haynes Duncan H |
Method of inducing local anesthesia using microdroplets of a general anesthetic
|
US4725442A
(en)
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
FR2562543B1
(fr)
|
1984-04-10 |
1987-09-25 |
Elf Aquitaine |
Nouveaux phosphonites cycliques, leur preparation et applications
|
US4891225A
(en)
|
1984-05-21 |
1990-01-02 |
Massachusetts Institute Of Technology |
Bioerodible polyanhydrides for controlled drug delivery
|
US4683194A
(en)
|
1984-05-29 |
1987-07-28 |
Cetus Corporation |
Method for detection of polymorphic restriction sites and nucleic acid sequences
|
NL8403224A
(nl)
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
KR880000094B1
(ko)
|
1984-12-07 |
1988-02-23 |
보령제약 주식회사 |
뉴클레오시드 유도체의 제조방법
|
JPS61204193A
(ja)
|
1985-03-05 |
1986-09-10 |
Takeda Chem Ind Ltd |
シトシンヌクレオシド類の製造法
|
US5223263A
(en)
*
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
US6448392B1
(en)
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
JPS61212592A
(ja)
|
1985-03-19 |
1986-09-20 |
Tokyo Tanabe Co Ltd |
D−リボ−スの製造方法
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
US4605659A
(en)
|
1985-04-30 |
1986-08-12 |
Syntex (U.S.A.) Inc. |
Purinyl or pyrimidinyl substituted hydroxycyclopentane compounds useful as antivirals
|
JPS61263995A
(ja)
|
1985-05-16 |
1986-11-21 |
Takeda Chem Ind Ltd |
シトシンヌクレオシド類の製造法
|
US4754026A
(en)
*
|
1985-06-04 |
1988-06-28 |
Takeda Chemical Industries, Ltd. |
Conversion of uracil derivatives to cytosine derivatives
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
US4889818A
(en)
|
1986-08-22 |
1989-12-26 |
Cetus Corporation |
Purified thermostable enzyme
|
US5079352A
(en)
|
1986-08-22 |
1992-01-07 |
Cetus Corporation |
Purified thermostable enzyme
|
IT1198449B
(it)
|
1986-10-13 |
1988-12-21 |
F I D I Farmaceutici Italiani |
Esteri di alcoli polivalenti di acido ialuronico
|
JPH0699467B2
(ja)
|
1987-03-04 |
1994-12-07 |
ヤマサ醤油株式会社 |
2▲’▼−デオキシ−2▲’▼(s)−アルキルピリミジンヌクレオシド誘導体
|
US5718921A
(en)
|
1987-03-13 |
1998-02-17 |
Massachusetts Institute Of Technology |
Microspheres comprising polymer and drug dispersed there within
|
DE3714473A1
(de)
|
1987-04-30 |
1988-11-10 |
Basf Ag |
Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
|
GB8719367D0
(en)
|
1987-08-15 |
1987-09-23 |
Wellcome Found |
Therapeutic compounds
|
US5246924A
(en)
|
1987-09-03 |
1993-09-21 |
Sloan-Kettering Institute For Cancer Research |
Method for treating hepatitis B virus infections using 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil
|
EP0380558A4
(en)
|
1987-09-22 |
1991-07-31 |
The Regents Of The University Of California |
Liposomal nucleoside analogues for treating aids
|
US4880784A
(en)
|
1987-12-21 |
1989-11-14 |
Brigham Young University |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
|
US5749847A
(en)
|
1988-01-21 |
1998-05-12 |
Massachusetts Institute Of Technology |
Delivery of nucleotides into organisms by electroporation
|
IE60383B1
(en)
|
1988-05-27 |
1994-07-13 |
Elan Corp Plc |
Controlled release pharmaceutical formulation
|
NZ229453A
(en)
|
1988-06-10 |
1991-08-27 |
Univ Minnesota & Southern Rese |
A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
|
US5122517A
(en)
*
|
1988-06-10 |
1992-06-16 |
Regents Of The University Of Minnesota |
Antiviral combination comprising nucleoside analogs
|
GB8815265D0
(en)
*
|
1988-06-27 |
1988-08-03 |
Wellcome Found |
Therapeutic nucleosides
|
US6599887B2
(en)
|
1988-07-07 |
2003-07-29 |
Chimerix, Inc. |
Methods of treating viral infections using antiviral liponucleotides
|
US6252060B1
(en)
*
|
1988-07-07 |
2001-06-26 |
Nexstar Pharmaceuticals, Inc. |
Antiviral liponucleosides: treatment of hepatitis B
|
SE8802687D0
(sv)
|
1988-07-20 |
1988-07-20 |
Astra Ab |
Nucleoside derivatives
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
US5744600A
(en)
*
|
1988-11-14 |
1998-04-28 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Phosphonomethoxy carbocyclic nucleosides and nucleotides
|
US5616702A
(en)
|
1988-11-15 |
1997-04-01 |
Merrell Pharmaceuticals Inc. |
2-'-ethenylidene cytidine, uridine and guanosine derivatives
|
US5356630A
(en)
|
1989-02-22 |
1994-10-18 |
Massachusetts Institute Of Technology |
Delivery system for controlled release of bioactive factors
|
US5705363A
(en)
*
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
US5411947A
(en)
*
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
US5194654A
(en)
*
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
US5026687A
(en)
|
1990-01-03 |
1991-06-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
|
US6060592A
(en)
*
|
1990-01-11 |
2000-05-09 |
Isis Pharmaceuticals, Inc. |
Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
|
IE66933B1
(en)
|
1990-01-15 |
1996-02-07 |
Elan Corp Plc |
Controlled absorption naproxen formulation for once-daily administration
|
US5200514A
(en)
*
|
1990-01-19 |
1993-04-06 |
University Of Georgia Research Foundation, Inc. |
Synthesis of 2'-deoxypyrimidine nucleosides
|
US5204466A
(en)
*
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
IE82916B1
(en)
|
1990-11-02 |
2003-06-11 |
Elan Corp Plc |
Formulations and their use in the treatment of neurological diseases
|
AU7872491A
(en)
|
1990-05-07 |
1991-11-27 |
Vical, Inc. |
Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
|
FR2662165B1
(fr)
|
1990-05-18 |
1992-09-11 |
Univ Paris Curie |
Derives nucleosidiques branches, leur procede de preparation et leur utilisation a titre de medicament.
|
WO1991018914A1
(en)
|
1990-05-29 |
1991-12-12 |
Vical, Inc. |
Synthesis of glycerol di- and triphosphate derivatives
|
CA2083961A1
(en)
*
|
1990-05-29 |
1991-11-30 |
Henk Van Den Bosch |
Synthesis of glycerol di- and triphosphate derivatives
|
AU651835B2
(en)
|
1990-06-13 |
1994-08-04 |
Arnold Glazier |
Phosphorous prodrugs
|
US5627165A
(en)
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
US5149543A
(en)
|
1990-10-05 |
1992-09-22 |
Massachusetts Institute Of Technology |
Ionically cross-linked polymeric microcapsules
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5372808A
(en)
|
1990-10-17 |
1994-12-13 |
Amgen Inc. |
Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
|
DE69128520T2
(de)
|
1990-10-31 |
1998-07-09 |
Tosoh Corp |
Verfahren zum Nachweis oder Quantifizierung von Zielnukleinsäuren
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
US5149794A
(en)
|
1990-11-01 |
1992-09-22 |
State Of Oregon |
Covalent lipid-drug conjugates for drug targeting
|
US5256641A
(en)
|
1990-11-01 |
1993-10-26 |
State Of Oregon |
Covalent polar lipid-peptide conjugates for immunological targeting
|
US5543389A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization |
Covalent polar lipid-peptide conjugates for use in salves
|
IL100502A
(en)
|
1991-01-03 |
1995-12-08 |
Iaf Biochem Int |
PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
|
JPH04266880A
(ja)
*
|
1991-02-22 |
1992-09-22 |
Japan Tobacco Inc |
3 −dpa− ラクトンの製造方法
|
ATE219366T1
(de)
|
1991-03-06 |
2002-07-15 |
Univ Emory |
Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
|
WO1992018517A1
(en)
|
1991-04-17 |
1992-10-29 |
Yale University |
Method of treating or preventing hepatitis b virus
|
US5994056A
(en)
|
1991-05-02 |
1999-11-30 |
Roche Molecular Systems, Inc. |
Homogeneous methods for nucleic acid amplification and detection
|
US5157027A
(en)
|
1991-05-13 |
1992-10-20 |
E. R. Squibb & Sons, Inc. |
Bisphosphonate squalene synthetase inhibitors and method
|
DK51092D0
(da)
|
1991-05-24 |
1992-04-15 |
Ole Buchardt |
Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
|
EP0594677A4
(en)
|
1991-07-12 |
1997-09-17 |
Vical Inc |
Antiviral liponucleosides: treatment of hepatitis b
|
JPH0525152A
(ja)
|
1991-07-22 |
1993-02-02 |
Japan Tobacco Inc |
3−dpa−ラクトンの製造法
|
US5554728A
(en)
|
1991-07-23 |
1996-09-10 |
Nexstar Pharmaceuticals, Inc. |
Lipid conjugates of therapeutic peptides and protease inhibitors
|
TW224053B
(pt)
|
1991-09-13 |
1994-05-21 |
Paul B Chretien |
|
DE69220808T2
(de)
|
1991-11-13 |
1998-01-02 |
Elan Corp Plc |
Vorrichtung zur verabreichung von heilmitteln
|
DE69230693T2
(de)
|
1991-11-14 |
2000-06-15 |
Dgi Inc |
Nicht-radioaktives hybridisations testverfahren und satz
|
MX9207334A
(es)
|
1991-12-18 |
1993-08-01 |
Glaxo Inc |
Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
DE4207363A1
(de)
|
1992-03-04 |
1993-09-09 |
Max Delbrueck Centrum |
Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
US5256797A
(en)
|
1992-06-22 |
1993-10-26 |
Eli Lilly And Company |
Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
|
US5371210A
(en)
|
1992-06-22 |
1994-12-06 |
Eli Lilly And Company |
Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
US5606048A
(en)
*
|
1992-06-22 |
1997-02-25 |
Eli Lilly And Company |
Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
|
US5401861A
(en)
*
|
1992-06-22 |
1995-03-28 |
Eli Lilly And Company |
Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
|
US5821357A
(en)
|
1992-06-22 |
1998-10-13 |
Eli Lilly And Company |
Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides
|
WO1994001117A1
(en)
|
1992-07-02 |
1994-01-20 |
The Wellcome Foundation Limited |
Therapeutic nucleosides
|
DE4224737A1
(de)
|
1992-07-27 |
1994-02-03 |
Herbert Prof Dr Schott |
Neue Cytosinnucleosidanaloga, Verfahren zu ihrer Herstellung und ihre Verwendung
|
CA2105112C
(en)
|
1992-09-01 |
2005-08-02 |
Thomas C. Britton |
A process for anomerizing nucleosides
|
US6423489B1
(en)
|
1992-09-10 |
2002-07-23 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
US6174868B1
(en)
|
1992-09-10 |
2001-01-16 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of hepatitis C virus-associated diseases
|
US6433159B1
(en)
|
1992-09-10 |
2002-08-13 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus associated diseases
|
DK0662157T3
(da)
|
1992-09-10 |
2001-08-27 |
Isis Pharmaceuticals Inc |
Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme
|
US6391542B1
(en)
|
1992-09-10 |
2002-05-21 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for treatment of Hepatitis C virus-associated diseases
|
JPH06135988A
(ja)
|
1992-10-22 |
1994-05-17 |
Toagosei Chem Ind Co Ltd |
ヌクレオシド誘導体
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
GB9226729D0
(en)
|
1992-12-22 |
1993-02-17 |
Wellcome Found |
Therapeutic combination
|
JPH06211890A
(ja)
|
1993-01-12 |
1994-08-02 |
Yamasa Shoyu Co Ltd |
2’−デオキシ−2’(s)−置換アルキルシチジン誘導体
|
JPH06228186A
(ja)
|
1993-01-29 |
1994-08-16 |
Yamasa Shoyu Co Ltd |
2’−デオキシ−(2’s)−アルキルピリミジンヌクレオシド誘導体
|
CA2156394A1
(en)
|
1993-02-24 |
1994-09-01 |
Jui H. Wang |
Compositions and methods of application of reactive antiviral polymers
|
GB9307043D0
(en)
|
1993-04-05 |
1993-05-26 |
Norsk Hydro As |
Chemical compounds
|
JP3693357B2
(ja)
|
1993-04-09 |
2005-09-07 |
峯郎 実吉 |
逆転写酵素阻害剤
|
EP0746319A4
(en)
|
1993-05-12 |
1997-11-05 |
Karl Y Hostetler |
ACYCLOVIR DERIVATIVES FOR TOPICAL USE
|
CA2167537A1
(en)
|
1993-07-19 |
1995-02-02 |
Tsuneo Ozeki |
Hepatitis c virus proliferation inhibitor
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
US6156501A
(en)
|
1993-10-26 |
2000-12-05 |
Affymetrix, Inc. |
Arrays of modified nucleic acid probes and methods of use
|
US5587362A
(en)
|
1994-01-28 |
1996-12-24 |
Univ. Of Ga Research Foundation |
L-nucleosides
|
US5419917A
(en)
|
1994-02-14 |
1995-05-30 |
Andrx Pharmaceuticals, Inc. |
Controlled release hydrogel formulation
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
JPH0821872A
(ja)
|
1994-07-07 |
1996-01-23 |
Nec Corp |
レーザ・レーダ装置
|
DE4432623A1
(de)
|
1994-09-14 |
1996-03-21 |
Huels Chemische Werke Ag |
Verfahren zur Bleichung von wäßrigen Tensidlösungen
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
US5728402A
(en)
|
1994-11-16 |
1998-03-17 |
Andrx Pharmaceuticals Inc. |
Controlled release formulation of captopril or a prodrug of captopril
|
RU2130029C1
(ru)
*
|
1994-12-13 |
1999-05-10 |
Тайхо Фармасьютикал Ко., Лтд. |
3'-замещенные производные нуклеозида, способ их получения (варианты), лекарственное средство, способ лечения и профилактики
|
US6475721B2
(en)
|
1995-03-04 |
2002-11-05 |
Boston Probes, Inc. |
Sequence specific detection of nucleic acids using a solid carrier bound with nucleic acid analog probes
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
JP3786447B2
(ja)
|
1995-03-31 |
2006-06-14 |
エーザイ株式会社 |
C型肝炎の予防・治療剤
|
IE75744B1
(en)
|
1995-04-03 |
1997-09-24 |
Elan Corp Plc |
Controlled release biodegradable micro- and nanospheres containing cyclosporin
|
DE19513330A1
(de)
*
|
1995-04-03 |
1996-10-10 |
Schering Ag |
Neues Verfahren zur Herstellung von Nucleosiden
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
US5558879A
(en)
|
1995-04-28 |
1996-09-24 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water soluble drugs in which a passageway is formed in situ
|
US6201065B1
(en)
|
1995-07-28 |
2001-03-13 |
Focal, Inc. |
Multiblock biodegradable hydrogels for drug delivery and tissue treatment
|
JPH0959292A
(ja)
|
1995-08-25 |
1997-03-04 |
Yamasa Shoyu Co Ltd |
4−アミノピリミジンヌクレオシドの製造法
|
AU709345B2
(en)
|
1995-09-07 |
1999-08-26 |
Emory University |
Therapeutic azide compounds
|
WO1997012033A1
(en)
|
1995-09-27 |
1997-04-03 |
Emory University |
Recombinant hepatitis c virus rna replicase
|
US5908621A
(en)
*
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
US5980884A
(en)
|
1996-02-05 |
1999-11-09 |
Amgen, Inc. |
Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
|
US5830905A
(en)
|
1996-03-29 |
1998-11-03 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
US5633388A
(en)
|
1996-03-29 |
1997-05-27 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment of hepatitis C
|
GB9609932D0
(en)
*
|
1996-05-13 |
1996-07-17 |
Hoffmann La Roche |
Use of IL-12 and IFN alpha for the treatment of infectious diseases
|
US5891874A
(en)
|
1996-06-05 |
1999-04-06 |
Eli Lilly And Company |
Anti-viral compound
|
JP3927630B2
(ja)
|
1996-09-27 |
2007-06-13 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ウイルス感染症の予防・治療剤
|
US5922757A
(en)
|
1996-09-30 |
1999-07-13 |
The Regents Of The University Of California |
Treatment and prevention of hepatic disorders
|
PL187107B1
(pl)
|
1996-10-16 |
2004-05-31 |
Icn Pharmaceuticals |
L-nukleozydy monocykliczne, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
|
KR100412480B1
(ko)
|
1996-10-16 |
2003-12-31 |
아이씨엔 파마슈티컬스, 인코포레이티드 |
푸린 l-누클레오시드, 이의 유사체 및 이들의 용도
|
UA79749C2
(en)
|
1996-10-18 |
2007-07-25 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
NZ335000A
(en)
*
|
1996-10-28 |
2000-12-22 |
Univ Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
US6248878B1
(en)
*
|
1996-12-24 |
2001-06-19 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside analogs
|
GB9708611D0
(en)
|
1997-04-28 |
1997-06-18 |
Univ Cardiff |
Chemical compounds
|
US6617422B1
(en)
|
1997-05-23 |
2003-09-09 |
Peter Nielsen |
Peptide nucleic acid monomers and oligomers
|
CN1136187C
(zh)
|
1997-06-30 |
2004-01-28 |
莫茨股份公司 |
1-氨基烷基环己烷nmda受体拮抗剂
|
IL134233A0
(en)
|
1997-08-11 |
2001-04-30 |
Boehringer Ingelheim Ca Ltd |
Hepatitis c inhibitor peptide analogues
|
US6472373B1
(en)
|
1997-09-21 |
2002-10-29 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
|
EP1136075B1
(en)
|
1997-09-21 |
2003-01-15 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
US6172046B1
(en)
*
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
CA2307002C
(en)
|
1997-10-30 |
2008-07-29 |
Raymond W. Klecker |
Antitumour uridine analogues
|
US6265174B1
(en)
|
1997-11-03 |
2001-07-24 |
Morphochem, Inc. |
Methods and compositions for identifying and modulating ctionprotein-interactions
|
AU2787199A
(en)
*
|
1998-02-25 |
1999-09-15 |
Emory University |
2'-fluoronucleosides
|
KR100389853B1
(ko)
*
|
1998-03-06 |
2003-08-19 |
삼성전자주식회사 |
카타로그정보의기록및재생방법
|
CA2322487C
(en)
|
1998-03-06 |
2010-07-20 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
US6312662B1
(en)
*
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
GB9806815D0
(en)
|
1998-03-30 |
1998-05-27 |
Hoffmann La Roche |
Amino acid derivatives
|
TW466112B
(en)
|
1998-04-14 |
2001-12-01 |
Lilly Co Eli |
Novel use of 2'-deoxy-2',2'-difluorocytidine for immunosuppressive therapy and pharmaceutical composition comprising the same
|
WO1999059621A1
(en)
|
1998-05-15 |
1999-11-25 |
Schering Corporation |
Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having g chronic hepatitis c infection
|
US6833361B2
(en)
*
|
1998-05-26 |
2004-12-21 |
Ribapharm, Inc. |
Nucleosides having bicyclic sugar moiety
|
CZ298681B6
(cs)
*
|
1998-06-08 |
2007-12-19 |
F. Hoffmann-La Roche Ag |
Lécivo pro lécení infekcí chronické hepatitis C
|
DK2415776T3
(en)
*
|
1998-08-10 |
2016-07-04 |
Novartis Ag |
Beta-L-2'-deoxy nucleosides for the treatment of Hepatitis B
|
US6444652B1
(en)
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
US6277830B1
(en)
|
1998-10-16 |
2001-08-21 |
Schering Corporation |
5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
|
CA2252144A1
(en)
|
1998-10-16 |
2000-04-16 |
University Of Alberta |
Dual action anticancer prodrugs
|
FR2784892B1
(fr)
|
1998-10-23 |
2001-04-06 |
Smith & Nephew Kinetec Sa |
Attelle de mobilisation passive repliable pour membre inferieur
|
AU774720B2
(en)
|
1998-11-05 |
2004-07-08 |
Centre National De La Recherche Scientifique |
Nucleosides with anti-hepatitis B virus activity
|
MXPA01004505A
(es)
|
1998-11-05 |
2005-04-19 |
Centre Nat Rech Scient |
Beta-l-2'desoxinucleosidos para el tratamiento de la infeccion por vih.
|
AR021876A1
(es)
|
1998-12-18 |
2002-08-07 |
Schering Corp |
Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado
|
JP2002537396A
(ja)
*
|
1999-02-22 |
2002-11-05 |
バイオケム ファーマ インコーポレイテッド |
抗ウィルス活性を有する[1,8]ナフチリジン誘導体
|
DE60030263T2
(de)
|
1999-03-05 |
2007-08-30 |
Metabasis Therapeutics, Inc., La Jolla |
Neue phosphor enthaltende medikamentenvorläuferverbindungen
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
AU7361400A
(en)
*
|
1999-09-08 |
2001-04-10 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
WO2001032153A2
(en)
|
1999-11-04 |
2001-05-10 |
Shire Biochem Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
AU784370B2
(en)
|
1999-12-22 |
2006-03-23 |
Metabasis Therapeutics, Inc. |
Novel bisamidate phosphonate prodrugs
|
AU2338101A
(en)
|
1999-12-30 |
2001-07-16 |
Biochem Pharma Inc. |
Imidazopyrimidine nucleoside analogues with anti-hiv activity
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
US6455508B1
(en)
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
US7056895B2
(en)
*
|
2000-02-15 |
2006-06-06 |
Valeant Pharmaceuticals International |
Tirazole nucleoside analogs and methods for using same
|
PL364995A1
(en)
|
2000-02-18 |
2004-12-27 |
Shire Biochem Inc. |
Method for the treatment or prevention of flavivirus
|
US6962906B2
(en)
|
2000-03-14 |
2005-11-08 |
Active Motif |
Oligonucleotide analogues, methods of synthesis and methods of use
|
WO2001079246A2
(en)
|
2000-04-13 |
2001-10-25 |
Pharmasset, Ltd. |
3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
|
GB0009486D0
(en)
|
2000-04-17 |
2000-06-07 |
Univ Cardiff |
Chemical compounds
|
EP1282632A1
(en)
|
2000-04-20 |
2003-02-12 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
|
GB0011203D0
(en)
|
2000-05-09 |
2000-06-28 |
Univ Cardiff |
Chemical compounds
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EA200601591A1
(ru)
*
|
2000-05-26 |
2007-02-27 |
Айденикс (Кайман) Лимитед |
Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
ES2227203T3
(es)
|
2000-05-26 |
2005-04-01 |
Idenix (Cayman) Limited |
Metodos para tratar la infeccion por el virus de la hepatitis delta con beta-1-2'-desoxinucleosidos.
|
MY141594A
(en)
|
2000-06-15 |
2010-05-14 |
Novirio Pharmaceuticals Ltd |
3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
|
US6875751B2
(en)
*
|
2000-06-15 |
2005-04-05 |
Idenix Pharmaceuticals, Inc. |
3′-prodrugs of 2′-deoxy-β-L-nucleosides
|
US6815542B2
(en)
*
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
US20030008841A1
(en)
*
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
ATE491459T1
(de)
*
|
2000-10-18 |
2011-01-15 |
Pharmasset Inc |
Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation
|
US20020127203A1
(en)
|
2000-10-18 |
2002-09-12 |
Albrecht Janice K. |
Ribavirin-pegylated interferon alfa HCV combination therapy
|
EP2145965A1
(en)
|
2000-10-18 |
2010-01-20 |
Pharmasset, Inc. |
Multiplex quantification of nucleic acids in diseased cells
|
WO2002048165A2
(en)
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
US7105499B2
(en)
*
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
AU2002243791B2
(en)
*
|
2001-01-22 |
2006-06-29 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
CA2439836A1
(en)
|
2001-03-01 |
2002-09-12 |
Pharmasset Ltd. |
Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
KR20050059975A
(ko)
|
2001-06-22 |
2005-06-21 |
파마셋 인코포레이티드 |
β-2'- 또는 3'-할로뉴클레오시드
|
WO2003024461A1
(en)
*
|
2001-09-20 |
2003-03-27 |
Schering Corporation |
Hcv combination therapy
|
US7138376B2
(en)
|
2001-09-28 |
2006-11-21 |
Idenix Pharmaceuticals, Inc. |
Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
|
EP1438054A4
(en)
*
|
2001-09-28 |
2006-07-26 |
Idenix Cayman Ltd |
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS USING MODIFIED NUCLEOSIDE AT 4 'POSITION
|
WO2003039523A2
(en)
|
2001-11-05 |
2003-05-15 |
Exiqon A/S |
OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
|
WO2003063771A2
(en)
*
|
2001-12-14 |
2003-08-07 |
Pharmasset Ltd. |
N4-acylcytosine nucleosides for treatment of viral iinfections
|
WO2003051899A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
US6965066B1
(en)
|
2002-01-16 |
2005-11-15 |
Actodyne General, Inc. |
Elongated string support for a stringed musical instrument
|
AU2002341942A1
(en)
|
2002-01-17 |
2003-09-02 |
Ribapharm Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
WO2003061385A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
Tricyclic nucleoside library compounds, synthesis, and use as antiviral agents
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
WO2003068244A1
(en)
|
2002-02-13 |
2003-08-21 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
US20040002476A1
(en)
|
2002-02-14 |
2004-01-01 |
Stuyver Lieven J. |
Modified fluorinated nucleoside analogues
|
RU2004128943A
(ru)
|
2002-02-28 |
2005-04-20 |
Байота, Инк. (Us) |
Средства, имитирующие нуклеотиды, и их пролекарственные формы
|
US6917041B2
(en)
|
2002-03-18 |
2005-07-12 |
Massachusetts Institute Of Technology |
Event-driven charge-coupled device design and applications therefor
|
US7247621B2
(en)
*
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
MXPA04010983A
(es)
*
|
2002-05-06 |
2005-02-14 |
Genelabs Tech Inc |
Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
|
US20040014957A1
(en)
|
2002-05-24 |
2004-01-22 |
Anne Eldrup |
Oligonucleotides having modified nucleoside units
|
AU2003241621A1
(en)
|
2002-05-24 |
2003-12-12 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
EP1515971A2
(en)
|
2002-06-17 |
2005-03-23 |
Merck & Co., Inc. |
Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
DE10226932A1
(de)
|
2002-06-17 |
2003-12-24 |
Bayer Ag |
Strahlenhärtende Beschichtungsmittel
|
EP1551421A2
(en)
|
2002-06-21 |
2005-07-13 |
Merck & Co. Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
EP1572945A2
(en)
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
BR0312271A
(pt)
|
2002-06-28 |
2007-11-06 |
Idenix Cayman Ltd |
compostos, composições e seus usos para o tratamento de infecções por flaviviridae
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
CN101172993A
(zh)
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
BR0312278A
(pt)
|
2002-06-28 |
2007-06-19 |
Idenix Cayman Ltd |
éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
|
AU2003269902A1
(en)
|
2002-07-16 |
2004-02-02 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
AU2003256619A1
(en)
|
2002-07-24 |
2004-02-09 |
Isis Pharmaceuticals, Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
US20040067877A1
(en)
|
2002-08-01 |
2004-04-08 |
Schinazi Raymond F. |
2', 3'-Dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections
|
AU2003261659A1
(en)
|
2002-09-16 |
2004-04-30 |
Kyeong Ho Kim |
Decoration band
|
US7094768B2
(en)
*
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
AU2003279797B2
(en)
|
2002-09-30 |
2009-10-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
AU2003291726A1
(en)
|
2002-11-04 |
2004-06-07 |
Xenoport, Inc. |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
|
EP2957568B1
(en)
|
2002-11-05 |
2016-12-21 |
Ionis Pharmaceuticals, Inc. |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
|
CA2504554A1
(en)
|
2002-11-05 |
2004-05-27 |
Isis Pharmaceuticals, Inc. |
2'-substituted oligomeric compounds and compositions for use in gene modulations
|
DK1576138T3
(en)
|
2002-11-15 |
2017-05-01 |
Idenix Pharmaceuticals Llc |
2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
US7598373B2
(en)
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
US20040181051A1
(en)
|
2002-12-23 |
2004-09-16 |
Richard Storer |
Process for the production of 3'-nucleoside prodrugs
|
WO2004065398A2
(en)
|
2003-01-15 |
2004-08-05 |
Ribapharm Inc. |
Synthesis and use of 2'-substituted-n6-modified nucleosides
|
AR043006A1
(es)
|
2003-02-12 |
2005-07-13 |
Merck & Co Inc |
Proceso para preparar ribonucleosidos ramificados
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
CN101415719A
(zh)
|
2003-03-20 |
2009-04-22 |
微生物化学及药品有限公司 |
生产2’-脱氧-β-L-核苷的方法
|
BRPI0408846A
(pt)
|
2003-03-28 |
2006-07-04 |
Pharmasset Inc |
compostos para o tratamento de infecções por flaviviridae
|
NZ542342A
(en)
|
2003-04-25 |
2009-05-31 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
KR20060015542A
(ko)
|
2003-04-28 |
2006-02-17 |
이데닉스 (케이만) 리미티드 |
산업 규모의 뉴클레오시드 합성
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
EP2345658A1
(en)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modified fluorinated nucleoside analogues
|
MXPA05013452A
(es)
*
|
2003-06-19 |
2006-03-09 |
Hoffmann La Roche |
Proceso para preparar derivados de 4'-azidonucleosido.
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
NZ546055A
(en)
|
2003-08-27 |
2010-05-28 |
Biota Scient Management |
Novel tricyclic nucleosides or nucleotides as therapeutic agents
|
WO2005030258A2
(en)
|
2003-09-22 |
2005-04-07 |
Acidophil Llc |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
US7151089B2
(en)
*
|
2003-10-27 |
2006-12-19 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
US20050137141A1
(en)
*
|
2003-10-24 |
2005-06-23 |
John Hilfinger |
Prodrug composition
|
CA2542776A1
(en)
|
2003-10-27 |
2005-05-12 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
EP1687321A1
(en)
|
2003-10-27 |
2006-08-09 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
GB0401088D0
(en)
|
2004-01-19 |
2004-02-18 |
Univ Cardiff |
Phosphoramidate derivatives
|
WO2006016930A2
(en)
|
2004-05-14 |
2006-02-16 |
Intermune, Inc. |
Methods for treating hcv infection
|
WO2005123087A2
(en)
|
2004-06-15 |
2005-12-29 |
Merck & Co., Inc. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
WO2006002231A1
(en)
|
2004-06-22 |
2006-01-05 |
Biocryst Pharmaceuticals, Inc. |
Aza nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
RU2007102281A
(ru)
|
2004-06-23 |
2008-07-27 |
Айденикс (Кайман) Лимитед (Ky) |
5-аза-7-деазапуриновые производные для лечения заболеваний, связанных с flaviviridae
|
US20070265222A1
(en)
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
NZ552927A
(en)
|
2004-07-21 |
2010-05-28 |
Pharmasset Inc |
Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
|
EP3539546A1
(en)
|
2004-07-27 |
2019-09-18 |
Gilead Sciences, Inc. |
Phosphonate analogs of hiv inhibitor compounds
|
CN101044151B
(zh)
*
|
2004-08-23 |
2011-01-19 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-叠氮基-核苷
|
JP2008514639A
(ja)
|
2004-09-24 |
2008-05-08 |
イデニクス(ケイマン)リミテツド |
フラビウイルス、ペスチウイルス及びヘパシウイルスの感染症を治療するための方法及び組成物
|
MX2007003853A
(es)
|
2004-10-06 |
2007-11-21 |
Migenix Inc |
Composiciones antivirales en combinacion que comprenden castanospermina y metodos de uso.
|
WO2006065335A2
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
|
US7414031B2
(en)
*
|
2004-11-22 |
2008-08-19 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
EP1828217A2
(en)
|
2004-12-16 |
2007-09-05 |
Febit Biotech GmbH |
Polymerase-independent analysis of the sequence of polynucleotides
|
EP1853317A2
(en)
|
2005-02-09 |
2007-11-14 |
Migenix Inc. |
Compositions and methods for treating or preventing flaviviridae infections
|
CA2600359A1
(en)
|
2005-03-09 |
2006-09-09 |
Idenix (Cayman) Limited |
Nucleosides with non-natural bases as anti-viral agents
|
US8163744B2
(en)
|
2005-03-18 |
2012-04-24 |
Nexuspharma, Inc. |
Tetrahydro-isoquinolin-1-ones for the treatment of cancer
|
DE102005012681A1
(de)
|
2005-03-18 |
2006-09-21 |
Weber, Lutz, Dr. |
Neue 1,5-Dihydro-pyrrol-2-one
|
GT200600119A
(es)
|
2005-03-24 |
2006-10-25 |
|
Composiciones farmaceuticas
|
TW200720285A
(en)
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
EP1893198A2
(en)
|
2005-05-31 |
2008-03-05 |
Novartis AG |
Treatment of liver diseases in which iron plays a role in pathogenesis
|
US20100017895A1
(en)
|
2005-07-18 |
2010-01-21 |
Amy Weiner |
Small animal model for hcv replication
|
US7632821B2
(en)
|
2005-08-09 |
2009-12-15 |
Merck & Co., Inc. |
Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection
|
WO2007022073A2
(en)
|
2005-08-12 |
2007-02-22 |
Merck & Co., Inc. |
Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives
|
AR057096A1
(es)
|
2005-08-26 |
2007-11-14 |
Chancellors Masters And Schola |
Proceso para preparar acidos y lactonas sacarinicos
|
EP1937825B1
(en)
|
2005-09-26 |
2016-12-21 |
Gilead Pharmasset LLC |
Modified 4'-nucleosides as antiviral agents
|
MY150667A
(en)
|
2005-12-09 |
2014-02-28 |
Gilead Pharmasset Llc |
Antiviral nucleosides
|
ES2422290T3
(es)
|
2005-12-23 |
2013-09-10 |
Idenix Pharmaceuticals Inc |
Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados
|
AU2007215114A1
(en)
|
2006-02-14 |
2007-08-23 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
PT2078080E
(pt)
|
2006-09-27 |
2015-09-18 |
Coley Pharm Gmbh |
Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada
|
SI2084174T1
(sl)
|
2006-10-10 |
2013-10-30 |
Gilead Pharmasset Llc |
Priprava nukleozidov ribofuranozil pririmidinov
|
GB0623493D0
(en)
|
2006-11-24 |
2007-01-03 |
Univ Cardiff |
Chemical compounds
|
JP2010513484A
(ja)
|
2006-12-20 |
2010-04-30 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Rna依存性rnaウイルス感染治療用ヌクレオシド環状ホスホロアミデート
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
WO2008100447A2
(en)
|
2007-02-09 |
2008-08-21 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
CA2685748A1
(en)
|
2007-05-14 |
2008-11-14 |
Rfs Pharma, Llc. |
Azido purine nucleosides for treatment of viral infections
|
US20090048189A1
(en)
|
2007-08-15 |
2009-02-19 |
Genelabs Technologies, Inc. |
Tricyclic-nucleoside compounds for treating viral infections
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
WO2009086192A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma, Inc. |
Biodegradable phosphate protected nucleotide derivatives and their use as cancer, anti viral and anti parasitic agents
|
EA020659B1
(ru)
|
2008-04-23 |
2014-12-30 |
Джилид Сайэнс, Инк. |
1'-замещённые карбануклеозидные аналоги для противовирусной терапии
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
CA2729168A1
(en)
|
2008-07-02 |
2010-02-04 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
PA8855801A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Sintesis de nucleosidos de purina
|
EP2376514A2
(en)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Nucleoside analogs
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
EP2393815A4
(en)
|
2009-02-06 |
2012-11-21 |
Rfs Pharma Llc |
PURIN NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR THE TREATMENT OF CANCER AND VIRUS INFECTIONS
|
UA112140C2
(uk)
|
2009-02-10 |
2016-07-25 |
Гіліад Сайєнсіз, Інк. |
Нуклеозидні похідіні (варіанти), фармацевтична композиція на їх основі, спосіб лікування вірусної інфекції та застосування сполуки для виробництва лікарського засобу
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
RU2553656C2
(ru)
|
2009-09-29 |
2015-06-20 |
ЯНССЕН ПРОДАКТС, Эл.Пи. |
Фосфорамидатные производные нуклеозидов
|
US8816074B2
(en)
|
2009-11-16 |
2014-08-26 |
University of Georgia Foundation, Inc. |
2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections
|
WO2011060408A2
(en)
|
2009-11-16 |
2011-05-19 |
University Of Georgia Research Foundation, Inc. |
2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
|
US8859756B2
(en)
|
2010-03-31 |
2014-10-14 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorus containing actives
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
MX2012011222A
(es)
|
2010-04-01 |
2013-01-18 |
Centre Nat Rech Scient |
Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
AR084393A1
(es)
|
2010-06-10 |
2013-05-15 |
Gilead Sciences Inc |
Metodos para tratar el virus de la hepatitis c, composicion, uso, combinacion, kit y uno o mas compuestos anti vhc
|
AP2013006665A0
(en)
|
2010-07-19 |
2013-01-31 |
Gilead Sciences Inc |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
WO2012087596A1
(en)
|
2010-12-20 |
2012-06-28 |
Gilead Sciences, Inc. |
Combinations for treating hcv
|
US9351989B2
(en)
|
2010-12-29 |
2016-05-31 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
US9095599B2
(en)
|
2011-01-03 |
2015-08-04 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
EA201391264A1
(ru)
|
2011-04-13 |
2014-03-31 |
Джилид Сайэнс, Инк. |
1'-замещенные пиримидиновые n-нуклеозидные аналоги для противовирусного лечения
|
EP2696679B1
(en)
|
2011-04-13 |
2017-08-02 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
PE20140522A1
(es)
|
2011-04-13 |
2014-05-03 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2'- sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
US9156872B2
(en)
|
2011-04-13 |
2015-10-13 |
Merck Sharp & Dohme Corp. |
2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
BR112013029761A2
(pt)
|
2011-05-19 |
2017-03-21 |
Univ Emory |
pró-drogas de monofosfato de purina para tratamento de infecções virais
|
EP2755985B1
(en)
|
2011-09-12 |
2017-11-01 |
Idenix Pharmaceuticals LLC |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
EP2755983B1
(en)
|
2011-09-12 |
2017-03-15 |
Idenix Pharmaceuticals LLC. |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
US8575119B2
(en)
|
2011-09-23 |
2013-11-05 |
Enanta Pharmaceuticals, Inc. |
2′-chloroacetylenyl substituted nucleoside derivatives
|
WO2013056046A1
(en)
|
2011-10-14 |
2013-04-18 |
Idenix Pharmaceuticals, Inc. |
Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
AP3913A
(en)
|
2012-05-22 |
2016-11-26 |
Idenix Pharamaceuticals Inc |
D-amino acid compounds for liver disease
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
EA030189B8
(ru)
|
2012-10-08 |
2018-10-31 |
Иденикс Фармасьютикалз Ллс |
Аналоги 2'-хлоронуклеозидов для инфекции вгс
|
US9242988B2
(en)
|
2012-10-17 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
AR092959A1
(es)
|
2012-10-17 |
2015-05-06 |
Merck Sharp & Dohme |
Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
US9457039B2
(en)
|
2012-10-17 |
2016-10-04 |
Merck Sharp & Dohme Corp. |
2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
EP2909223B1
(en)
|
2012-10-19 |
2017-03-22 |
Idenix Pharmaceuticals LLC |
Dinucleotide compounds for hcv infection
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
WO2014078427A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of rp-nucleoside analog
|
WO2014078436A1
(en)
|
2012-11-14 |
2014-05-22 |
Idenix Pharmaceuticals, Inc. |
D-alanine ester of sp-nucleoside analog
|
WO2014099941A1
(en)
|
2012-12-19 |
2014-06-26 |
Idenix Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
WO2014197578A1
(en)
|
2013-06-05 |
2014-12-11 |
Idenix Pharmaceuticals, Inc. |
1',4'-thio nucleosides for the treatment of hcv
|
US9765107B2
(en)
|
2013-06-18 |
2017-09-19 |
Merck Sharp & Dohme Corp. |
Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
EP3027636B1
(en)
|
2013-08-01 |
2022-01-05 |
Idenix Pharmaceuticals LLC |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|